Literature DB >> 9731720

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype.

J Grove1, A S Brown, A K Daly, M F Bassendine, O F James, C P Day.   

Abstract

Twin studies in Caucasians suggest that susceptibility to alcoholic liver disease is, in part, genetically determined. Because most of the deleterious effects of alcohol are caused by its metabolism, attention has focused upon genes encoding ethanol metabolizing enzymes. Caucasians are polymorphic at only two of these gene loci--cytochrome P450 2E1 (CYP2E1) and alcohol dehydrogenase 3 (ADH3). We examined the frequency of the RsaI polymorphism of CYP2E1 and ADH3 genotype in 264 patients with alcoholic liver disease and 121 local control individuals. There was a non-significant excess of the rare c2 CYP2E1 allele in patients with advanced liver disease compared with control individuals/patients with steatosis only (0.029 versus 0.017/0.00). However, patients with the c2 allele presented at a younger age compared with those with the wild type c1 allele only (42.3 +/- 1.6 years versus 49.0 +/- 0.6 years; P = 0.001) with at least as advanced histology (93% cirrhotic versus 74%). Male patients had a higher frequency of the ADH3*2/*2 genotype (which encodes the less active gamma2 subunit) than control individuals [odds ratio (OR) 2.04 (1.11-3.76)], however, ADH3 genotype did not differ with histological stage or with age of presentation. Patients with advanced disease possessing the c2 allele had a significantly higher frequency of the ADH3*2/*2 genotype compared with c1 homozygotes [OR 3.71 (1.24-11.09)]. This study demonstrates that, although rare in Caucasians, possession of the mutant c2 allele of CYP2E1 increases the risk of alcoholic liver disease at a given level of cumulative alcohol consumption. This risk appears to be particularly manifest in individuals carrying the ADH3*2 allele, presumably reflecting increased metabolism of ethanol by CYP2E1. In the absence of the c2 allele, ADH3 genotype does not influence the risk of advanced alcoholic liver disease but, in males at least, may influence the risk of alcoholism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731720     DOI: 10.1097/00008571-199808000-00007

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  21 in total

1.  Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

Authors:  N A Wong; F Rae; K J Simpson; G D Murray; D J Harrison
Journal:  Mol Pathol       Date:  2000-04

Review 2.  Candidate gene case-control association studies: advantages and potential pitfalls.

Authors:  A K Daly; C P Day
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

3.  Further clarification of the contribution of the ADH1C gene to vulnerability of alcoholism and selected liver diseases.

Authors:  Dawei Li; Hongyu Zhao; Joel Gelernter
Journal:  Hum Genet       Date:  2012-04-05       Impact factor: 4.132

4.  Alcoholic Liver Disease in Asia, Europe, and North America.

Authors:  Suthat Liangpunsakul; Paul Haber; Geoffrey W McCaughan
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

Review 5.  Alcoholic liver disease.

Authors:  K Walsh; G Alexander
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

6.  Subjective response to alcohol and ADH polymorphisms in a select sample of young adult male East Indians and Africans in Trinidad and Tobago.

Authors:  Lazara Karelia Montane Jaime; Samuel Shafe; Tiebing Liang; Derek N Wills; Greta I Berg; Cindy L Ehlers
Journal:  J Stud Alcohol Drugs       Date:  2014-09       Impact factor: 2.582

7.  Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases.

Authors:  N Assy; I Bekirov; Y Mejritsky; L Solomon; S Szvalb; O Hussein
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

8.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.

Authors:  E Albano; E Mottaran; M Vidali; E Reale; S Saksena; G Occhino; A D Burt; C P Day
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

9.  UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.

Authors:  Soumen K Manna; Andrew D Patterson; Qian Yang; Kristopher W Krausz; Jeffrey R Idle; Albert J Fornace; Frank J Gonzalez
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

10.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.